From: Clinical outcome and expression of mutant P53, P16, and Smad4 in lung adenocarcinoma: a prospective study
TP53
P16
Smad4
Mutant P53
  r
1.000
−0.132
−0.196
  P
-
0.150
0.032
0.182
0.047